Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 394

1.

Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature.

Bongiovanni A, Riva N, Calpona S, Ricci M, Gunelli E, Liverani C, La Manna F, De Vita A, Monti M, Severi S, Pieri F, Amadori E, Galassi R, Cavaliere D, Zaccaroni A, Tartaglia A, Lunedei V, Gardini A, Mercatali L, Amadori D, Ibrahim T.

Onco Targets Ther. 2014 Oct 20;7:1919-26. doi: 10.2147/OTT.S68573. eCollection 2014.

PMID:
25364262
[PubMed]
Free PMC Article
2.

Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients?

Farolfi A, Carretta E, Luna CD, Ragazzini A, Gentili N, Casadei C, Barone D, Minguzzi M, Amadori D, Nanni O, Gavelli G.

BMC Cancer. 2014 Oct 31;14:792. doi: 10.1186/1471-2407-14-792.

PMID:
25361734
[PubMed - in process]
Free PMC Article
3.

Clinical and Genetic Factors Related to Cancer-Induced Bone Pain and Bone Pain Relief.

Scarpi E, Calistri D, Klepstad P, Kaasa S, Skorpen F, Habberstad R, Nanni O, Amadori D, Maltoni M.

Oncologist. 2014 Oct 23. pii: theoncologist.2014-0174. [Epub ahead of print]

PMID:
25342315
[PubMed - as supplied by publisher]
4.

Single bone metastasis from adenocarcinoma of the lacrimal gland: a case report.

Ricci M, Amadori E, Chiesa F, Bongiovanni A, Liverani C, Fabbri L, Falasconi MC, Casadei R, Oboldi D, Galassi R, Micheletti S, Severi S, Serra L, Pieri F, Calabrese L, Riva N, Calpona S, Gunelli E, Mercatali L, Amadori D, Ibrahim T.

Future Oncol. 2014 Aug;10(10):1735-9. doi: 10.2217/fon.14.36.

PMID:
25303054
[PubMed - in process]
5.

Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide.

Conteduca V, Burgio SL, Menna C, Carretta E, Rossi L, Bianchi E, Masini C, Amadori D, De Giorgi U.

Prostate. 2014 Dec;74(16):1691-6. doi: 10.1002/pros.22890. Epub 2014 Sep 27.

PMID:
25262981
[PubMed - in process]
6.

New biomarkers to predict the evolution of in situ breast cancers.

Bravaccini S, Tumedei MM, Scarpi E, Zoli W, Rengucci C, Serra L, Curcio A, Buggi F, Folli S, Rocca A, Maltoni R, Puccetti M, Amadori D, Silvestrini R.

Biomed Res Int. 2014;2014:159765. doi: 10.1155/2014/159765. Epub 2014 Aug 26.

PMID:
25243117
[PubMed - in process]
Free PMC Article
7.

ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling.

Chakrabarti R, Wei Y, Hwang J, Hang X, Andres Blanco M, Choudhury A, Tiede B, Romano RA, DeCoste C, Mercatali L, Ibrahim T, Amadori D, Kannan N, Eaves CJ, Sinha S, Kang Y.

Nat Cell Biol. 2014 Oct;16(10):1004-15, 1-13. doi: 10.1038/ncb3040. Epub 2014 Sep 21.

PMID:
25241036
[PubMed - in process]
8.

Improved stool DNA integrity method for early colorectal cancer diagnosis.

Rengucci C, De Maio G, Menghi M, Scarpi E, Guglielmo S, Fusaroli P, Caletti G, Saragoni L, Casadei Gardini A, Zoli W, Falcini F, Amadori D, Calistri D.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2553-60. doi: 10.1158/1055-9965.EPI-14-0379. Epub 2014 Aug 15.

PMID:
25128402
[PubMed - in process]
9.

Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence.

Rengucci C, De Maio G, Casadei Gardini A, Zucca M, Scarpi E, Zingaretti C, Foschi G, Tumedei MM, Molinari C, Saragoni L, Puccetti M, Amadori D, Zoli W, Calistri D.

J Exp Clin Cancer Res. 2014 Aug 5;33(1):65. doi: 10.1186/s13046-014-0065-x.

PMID:
25091577
[PubMed - in process]
Free Article
10.

Discrepancies between VEGF -1154 G>A polymorphism analysis performed in peripheral blood samples and FFPE tissue.

Marisi G, Passardi A, Calistri D, Zoli W, Amadori D, Ulivi P.

Int J Mol Sci. 2014 Jul 30;15(8):13333-43. doi: 10.3390/ijms150813333.

PMID:
25079441
[PubMed - in process]
Free PMC Article
11.

Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy.

Cecconetto L, Casadei Gardini A, Tenti E, Maltoni R, Bravaccini S, Oboldi D, Zoli W, Serra P, Donati C, Sarti S, Amadori D, Rocca A.

Tumori. 2014 May-Jun;100(3):e79-82. doi: 10.1700/1578.17238.

PMID:
25076256
[PubMed - in process]
12.

Taxanes as a risk factor for acute adverse reactions to iodinated contrast media in cancer patients.

Farolfi A, Della Luna C, Ragazzini A, Carretta E, Gentili N, Casadei C, Aquilina M, Barone D, Minguzzi M, Amadori D, Nanni O, Gavelli G.

Oncologist. 2014 Aug;19(8):823-8. doi: 10.1634/theoncologist.2013-0470. Epub 2014 Jul 25.

PMID:
25063226
[PubMed - in process]
13.

First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer.

Tedaldi G, Danesi R, Zampiga V, Tebaldi M, Bedei L, Zoli W, Amadori D, Falcini F, Calistri D.

BMC Cancer. 2014 Jul 1;14:478. doi: 10.1186/1471-2407-14-478.

PMID:
24986639
[PubMed - in process]
Free PMC Article
14.

The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin.

Ell B, Qiu Q, Wei Y, Mercatali L, Ibrahim T, Amadori D, Kang Y.

J Biol Chem. 2014 Aug 8;289(32):21888-95. doi: 10.1074/jbc.M114.582866. Epub 2014 Jun 25.

PMID:
24966325
[PubMed - in process]
15.

CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems.

Liverani C, Mercatali L, Spadazzi C, La Manna F, De Vita A, Riva N, Calpona S, Ricci M, Bongiovanni A, Gunelli E, Zanoni M, Fabbri F, Zoli W, Amadori D, Ibrahim T.

Bone. 2014 Sep;66:214-22. doi: 10.1016/j.bone.2014.06.017. Epub 2014 Jun 20.

PMID:
24956020
[PubMed - in process]
16.

Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategies.

Conteduca V, Aieta M, Amadori D, De Giorgi U.

Crit Rev Oncol Hematol. 2014 Oct;92(1):11-24. doi: 10.1016/j.critrevonc.2014.05.008. Epub 2014 May 27.

PMID:
24952997
[PubMed - in process]
17.

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.

Taieb J, Tabernero J, Mini E, Subtil F, Folprecht G, Van Laethem JL, Thaler J, Bridgewater J, Petersen LN, Blons H, Collette L, Van Cutsem E, Rougier P, Salazar R, Bedenne L, Emile JF, Laurent-Puig P, Lepage C; PETACC-8 Study Investigators.

Lancet Oncol. 2014 Jul;15(8):862-73. doi: 10.1016/S1470-2045(14)70227-X. Epub 2014 Jun 11.

PMID:
24928083
[PubMed - indexed for MEDLINE]
18.

Management of Italian patients with advanced non-small-cell lung cancer after second-line treatment: results of the longitudinal phase of the LIFE observational study.

de Marinis F, Ardizzoni A, Fontanini G, Grossi F, Cappuzzo F, Novello S, Santo A, Lorusso V, Cortinovis D, Iurlaro M, Galetta D, Gridelli C; LIFE Study Team.

Clin Lung Cancer. 2014 Sep;15(5):338-45.e1. doi: 10.1016/j.cllc.2014.04.004. Epub 2014 May 14.

PMID:
24925809
[PubMed - in process]
19.

Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study.

Gridelli C, de Marinis F, Ardizzoni A, Novello S, Fontanini G, Cappuzzo F, Grossi F, Santo A, Cortinovis D, Favaretto A, Lorusso V, Galetta D, Siena S, Bettini A, Iurlaro M, Caprioli A; LIFE study team.

J Cancer Res Clin Oncol. 2014 Oct;140(10):1783-93. doi: 10.1007/s00432-014-1715-2. Epub 2014 Jun 6.

PMID:
24903964
[PubMed - indexed for MEDLINE]
20.

Erratum to: Is a clear benefit in survival enough to modify patient access to the surgery service? A retrospective analysis in a cohort of gastric cancer patients.

Altini M, Carretta E, Morgagni P, Carradori T, Ciotti E, Prati E, Garcea D, Amadori D, Falcini F, Nanni O.

Gastric Cancer. 2014 Apr 24. [Epub ahead of print] No abstract available.

PMID:
24760337
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk